pSpA: Drug-Free Remission

Clinical REmission in peripheral SPondyloArthritis (CRESPA): Golimumab Effective for Early Peripheral Spondyloarthritis

First results from the CRESPA trial show…
medscape.com

CRESPA: Drug-Free Remission Achieved in Early Peripheral SpA

More than half of patients with early peripheral spondyloarthritis stopped treatment after remission
medpagetoday.com

No Comments Yet.

Leave a comment